A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

This study has been completed.

Study NCT00051051 Information provided by Pfizer

First Received: January 2, 2003 Last Updated: May 3, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2005
Estimated Primary Completion Date:	No date given